Cargando…
Variation in health plan specialty drug coverage: an empirical analysis
Background: Patients’ access to specialty drugs is determined in part by their health plan. Because health plans develop their own coverage policies, coverage of specialty drugs can vary, which in turn may affect their members’ access to care. Aims: Our objective was to examine variation in how comm...
Autores principales: | Margaretos, Nikoletta M., Lai, Rachel C., Panzer, Ari D., Chambers, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764391/ http://dx.doi.org/10.1080/21556660.2019.1658290 |
Ejemplares similares
-
Variation in health plan coverage of ESAs for anemia due to chronic kidney disease
por: Margaretos, NikoLetta M, et al.
Publicado: (2021) -
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
por: Panzer, Ari D, et al.
Publicado: (2023) -
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
por: Levine, A. Alex, et al.
Publicado: (2023) -
Limited role of patient input in specialty drug coverage policies
por: D’Cruz, Brittany, et al.
Publicado: (2021) -
Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions
por: Chambers, James D, et al.
Publicado: (2023)